Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (THC). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: GlobalData
|
$250.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Tenet Healthcare Corp Reaffirms FY 2012 EBITDA Guidance
Tenet Healthcare Corp reaffirmed its fiscal 2012 adjusted EBITDA outlook in the range of $1.250-$1.375 Billion.
Latest Developments for Tenet Healthcare Corp
- Tenet Healthcare Corp Announces Private Offering of Senior Secured Notes
- Tenet Healthcare Corp Issues Q2 2013 EBITDA Guidance In Line With Analysts' Estimates; Reaffirms FY 2013 EBITDA Guidance
- Tenet Healthcare Corp Issues Q1 2013 EBITDA Guidance Below Analysts' Estimates; Reaffirms FY 2013 EBITDA Guidance
- Tenet Healthcare Corp Issues Q4 2012 EBITDA Guidance Below Analysts' Estimates; Raises FY 2012 EBITDA Guidance
Latest Key Developments in Healthcare
- Share this
- Link this
- Digg this
Follow Reuters